Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model

被引：0

作者：

Said Ahmed Bahwal

Jane J. Chen

Lilin E

Taofang Hao

Jiancong Chen

Vern B. Carruthers

Jiaming Lai

Xingwang Zhou

机构：

[1] Sun Yat-Sen University,Department of Biochemistry and Molecular Biology, Sun Yat

[2] Warren Alpert Medical School of Brown University,Sen University Zhongshan School of Medicine

[3] Sun Yat-Sen University,Department of Pancreato

[4] University of Michigan School of Medicine,Biliary Surgery, The First Affiliated Hospital

来源：

Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷

关键词：

Dendritic cells; Immunotherapy; Programmed cell death 1 receptor; Vaccination;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2743 / 2757

页数：14

共 50 条

[1] Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model
Bahwal, Said Ahmed
Chen, Jane J.
E, Lilin
Hao, Taofang
Chen, Jiancong
Carruthers, Vern B.
Lai, Jiaming
Zhou, Xingwang
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2743 - 2757
[2] Antitumor activity of eribulin in combination with anti-PD1 antibody in a mouse syngeneic breast cancer model
Semba, Taro
Tabata, Kimiyo
Ozawa, Yoichi
Miyano, Saori Watanabe
Matsui, Junji
Funahashi, Yasuhiro
CANCER RESEARCH, 2019, 79 (13)
[3] Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment
Lang, Julie
Capasso, Anna
Jordan, Kimberly R.
French, Jena D.
Kar, Adwitiya
Bagby, Stacey M.
Barbee, Jacob
Yacob, Betelehem W.
Head, Lia S.
Tompkins, Kenneth D.
Freed, Brian M.
Somerset, Hilary
Clark, Toshimasa J.
Pitts, Todd M.
Messersmith, Wells A.
Eckhardt, S. Gail
Wierman, Margaret E.
Leong, Stephen
Kiseljak-Vassiliades, Katja
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (01): : 26 - 42
[4] SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer
Yu, Jiahua
Yu, Shijun
Bai, Jin
Zhu, Zhe
Gao, Yong
Li, Yandong
CANCER GENE THERAPY, 2024, 31 (05) : 755 - 765
[5] SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer
Jiahua Yu
Shijun Yu
Jin Bai
Zhe Zhu
Yong Gao
Yandong Li
Cancer Gene Therapy, 2024, 31 : 755 - 765
[6] Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody
Kanaya, Nobuhiko
Kuroda, Shinji
Kakiuchi, Yoshihiko
Kumon, Kento
Tsumura, Tomoko
Hashimoto, Masashi
Morihiro, Toshiaki
Kubota, Tetsushi
Aoyama, Katsuyuki
Kikuchi, Satoru
Nishizaki, Masahiko
Kagawa, Shunsuke
Tazawa, Hiroshi
Mizuguchi, Hiroyuki
Urata, Yasuo
Fujiwara, Toshiyoshi
MOLECULAR THERAPY, 2020, 28 (03) : 794 - 804
[7] Anti-PD-1 antibody enhances antitumor efficacy of oncolytic HSV-1 G47 Δ in a mouse lung cancer model
Sakata, Yoshinori
Ino, Yasushi
Iwai, Miwako
Ikeda, Norihiko
Todo, Tomoki
CANCER SCIENCE, 2018, 109 : 1185 - 1185
[8] Imprime PGG drives adaptive immune resistance within the tumor microenvironment by modulating the myeloid compartment and enhances the efficacy of anti-PD1 antibody in vivo
Jonas, Adria L. Bykowski
Chan, Anissa S. H.
Ottoson, Nadine R.
Qiu, Xiaohong
Fraser, Kathryn
Kangas, Takashi O.
Fulton, Ross
Rathmann, Blaine
Graff, Jeremy R.
Bose, Nandita
CANCER RESEARCH, 2016, 76
[9] β-hydroxy-β-methylbutyrate enhances anti-PD1 immunotherapy in a mouse model of pancreatic ductal adenocarcinoma.
Etigunta, Suhas K.
Coleman, Michael F.
Pfeil, Alex J.
Lashinger, Laura M.
Cui, Zhengrong
Hursting, Stephen D.
CANCER RESEARCH, 2021, 81 (13)
[10] CABOZANTINIB ENHANCES THE EFFICACY AND IMMUNE MODULATORY ACTIVITY OF ANTI-PD1 TREATMENT IN A SYNGENEIC MOUSE MODEL OF HCC
Esteban-Fabro, Roger
Willoughby, Catherine E.
Pique-Gili, Marta
Peix, Judit
Abril-Fornaguera, Jordi
Pinyol, Roser
Llovet, Josep M.
HEPATOLOGY, 2019, 70 : 1201A - 1202A

← 1 2 3 4 5 →